Skip to main content

Diabetic Nephropathy clinical trials at UCSF
1 in progress, 1 open to new patients

  • Study Of Diabetic Nephropathy With Atrasentan

    open to eligible people ages 18 years to 85 years

    This study is being conducted to evaluate the effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.

    San Francisco, California and other locations